HIGHLIGHTS
- who: Anti-VEGF and collaborators from the Trial registration The study was approved through the Human Research Ethics Committee, University of Tasmania have published the article: Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in in clinical practice, in the Journal: (JOURNAL)
- what: The study shows a significant proportion of DME patients do not respond to therapy and identifies several clinical predictors for treatment outcomes. The aim of this study was, therefore, to assess outcome and the predictors of treatment response to anti-VEGF injections in routine clinical practice. This . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.